Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Baxter International Inc.

BAX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of BAX by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 May 27, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 15, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 01, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Apr 24, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Apr 13, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 30, 2026
Michael T. McCaul House / R Purchase $100,001 - $250,000 Feb 17, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 17, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 29, 2026
Michael T. McCaul House / R Purchase $50,001 - $100,000 Jan 13, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Nov 10, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Sep 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 03, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 26, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 26, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 12, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 12, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jul 22, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Jun 26, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 16, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 16, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 10, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 10, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 10, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 07, 2025
BAX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
BAX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BAX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in BAX holdings by institutional investors

Quarterly net insider trading by BAX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues

Former government officials who have lobbied for BAX

69 former government officials from 42 congressional offices at 14 lobbying firms have lobbied for BAX, most recently Oct 20, 2026.

  • Robert Alspach House Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); Counsel - E&C; Clerk - E&C; Paid Intern - E&C Formerly Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); C · LEAVITT PARTNERS, LLC · Oct 20, 2026
  • Melissa Pfaff Senate Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate Formerly Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Adv · LEAVITT PARTNERS, LLC · Oct 20, 2026
  • Michelle Adams Congress New Senior Policy Advisor, CBER; Senior Advisor Office of Commissioner FDA; Acting Director/Senior Specialist, Intergovernmental Affairs FDA; Congress Affairs Specialist FDA; Senior Health Leg Assistant Senate; Leg Director House; Leg Assistant House Formerly Senior Policy Advisor, CBER; Senior Advisor Office of Commissioner FDA; Acting D · LEAVITT PARTNERS, LLC · Oct 20, 2026
  • Mark Kirk
    Kate Dickens Senate Chief of Staff, US Sen Mark Kirk; Leg Director, Rep Mike Castle; Foreign Policy Adv, Rep. Connie Morella Formerly with Mark Kirk · S-3 GROUP · Oct 16, 2026
  • Susan M. Collins
    Olivia Kurtz Senate Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle Formerly with Susan M. Collins · S-3 GROUP · Oct 16, 2026
  • Steve Scalise
    Martin Reiser House Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee Formerly with Steve Scalise · S-3 GROUP · Oct 16, 2026
  • Nancy Pelosi
    Michael Long House Director of Member Services, Senior Advisor for SpeakerNancy Pelosi; Dep. Floor Director and Advisor, Dem Leader Nancy Pelosi; Special Asst and Staff Asst for Speaker Nancy Pelosi Formerly with Nancy Pelosi · S-3 GROUP · Oct 16, 2026
  • Denise L. Majette
    Michaeleen Crowell House Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders Formerly with Denise L. Majette · S-3 GROUP · Oct 16, 2026
See all 69 on the Revolving Door dashboard

BAX Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

BAX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
BAX Income Statement
BAX Balance Sheet
BAX Cash Flow
U.S. Patents

New BAX patent grants

  • Patent Title: Hemostatic sponge Jan. 23, 2018
  • Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Jan. 16, 2018
  • Patent Title: Catheter/fistula needle to bloodline connection assurance device Jan. 16, 2018
  • Patent Title: Battery management system Jan. 02, 2018
  • Patent Title: Dialysis system including heparin injection Jan. 02, 2018
  • Patent Title: Hemostatic compositions Dec. 05, 2017
  • Patent Title: Non-invasive radio frequency liquid level and volume detection system and method using phase shift Nov. 28, 2017
  • Patent Title: Percutaneous administration device and method for injecting medicinal substances Nov. 28, 2017
  • Patent Title: Nanoclay sorbents for dialysis Nov. 21, 2017
  • Patent Title: Hemostatic compositions Nov. 21, 2017
  • Patent Title: Weight-controlled sorbent system for hemodialysis Nov. 14, 2017
  • Patent Title: Drip chamber with hydrophobic interior surface Oct. 31, 2017
  • Patent Title: Method of controlling medical fluid therapy machine brightness Oct. 24, 2017
  • Patent Title: Blood treatment air purging methods Oct. 24, 2017
  • Patent Title: Pumping systems for cassette-based dialysis Oct. 24, 2017
  • Patent Title: Optical imaging assembly and system with optical distortion correction Oct. 17, 2017
  • Patent Title: Solenoid pinch valve apparatus and method for medical fluid applications having reduced noise production Oct. 10, 2017
  • Patent Title: Peritoneal dialysis systems and methods having graphical user interface Oct. 03, 2017
  • Patent Title: Systems and methods for performing dialysis Sep. 19, 2017
  • Patent Title: Systems and methods for performing hemodialysis Sep. 12, 2017
  • Patent Title: System and method for peritoneal dialysis exchanges having reusable fill and drain containers Sep. 05, 2017
  • Patent Title: Hybrid blood and peritoneal dialysis treatment systems and methods Aug. 29, 2017
  • Patent Title: Automated dialysis system using piston and negative pressure Aug. 29, 2017
  • Patent Title: Dialysis system having non-invasive fluid velocity sensing Aug. 08, 2017
  • Patent Title: Injectable fibrin composition for bone augmentation Aug. 08, 2017
  • Patent Title: Surfactant systems for delivery of organic compounds Jul. 11, 2017
  • Patent Title: Dialysis system having approved therapy prescriptions presented for selection Jul. 04, 2017
  • Patent Title: Methods and apparatus for programming a medical pump Jun. 27, 2017
  • Patent Title: Dialysis treatment prescription system and method Jun. 27, 2017
  • Patent Title: Peritoneal dialysis connection system and method for using ultraviolet light emitting diodes Jun. 27, 2017
  • Patent Title: Infusion pump and method to enhance long term medication delivery accuracy Jun. 20, 2017
  • Patent Title: Dialysis systems including therapy prescription entries Jun. 13, 2017
  • Patent Title: Method of operating a disposable pumping unit Jun. 13, 2017
  • Patent Title: Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products Jun. 06, 2017
  • Patent Title: Acoustic line tracing system and method for fluid transfer system May. 23, 2017
  • Patent Title: Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups May. 23, 2017
  • Patent Title: Renal failure therapy machines and methods including convective and diffusive clearance May. 09, 2017
  • Patent Title: Immobilization of an active agent on a substrate May. 09, 2017
  • Patent Title: Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis Apr. 25, 2017
  • Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Apr. 18, 2017
  • Patent Title: Pressure manifold system for dialysis Apr. 18, 2017
  • Patent Title: Sealant applicator with malleable section Apr. 18, 2017
  • Patent Title: Devices, systems, and methods for cleaning, disinfecting, rinsing, and priming blood separation devices and associated fluid lines Apr. 11, 2017
  • Patent Title: Infusion system using optical imager for controlling flow and method thereof Mar. 28, 2017
  • Patent Title: Medical fluid machine with supply autoconnection Mar. 07, 2017
  • Patent Title: Method of performing peritoneal dialysis using pneumatic valves Mar. 07, 2017
  • Patent Title: Networked dialysis system Feb. 28, 2017
  • Patent Title: Antimicrobial housing and cover for a medical device Feb. 21, 2017
  • Patent Title: Dialysis system with cassette based balance chambers and volumetric pumps Feb. 21, 2017
  • Patent Title: Preparations based on fibrinogen and sulfated polysaccharides Feb. 14, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to BAX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
BAX News

Recent insights relating to BAX

Political Exposure

Pending bills that may affect BAX

Bill
Impact
Confidence
Date
CNBC Recommendations

Recent picks made for BAX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BAX

BAX Analyst Ratings

BAX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
BAX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $BAX stock a Buy, Sell, or Hold?

  • What is the price target for $BAX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

BAX Top Shareholders
Shareholder
Shares Held
BAX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $BAX stock?

  • Who owns the most shares of $BAX stock?

  • What funds own $BAX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

BAX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BAX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About BAX

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

  • Address Deerfield, IL
  • Market Cap 13.2 billion
  • Employees 37,500
  • Industrial Classification Surgical & Medical Instruments & Apparatus

Baxter International Inc. (BAX) Historical Stock Prices

Daily open, high, low, close, adjusted close and volume for Baxter International Inc. (BAX).

See every congressional and insider trade on the BAX price chart

Quiver Premium charts BAX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Baxter International Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at BAX, per a recent SEC DEF 14A filing. We estimate that the median employee at BAXTER INTERNATIONAL INC is paid $70,331.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation